Future studies into the use of Ozempic and Wegovy will rely on academic funding as Ozempics manufacturers Novo Nordisk have no current plans to study the other applications for the drugs
ACS Chem Neurosci 16:818825 Dickson SL, Shirazi RH, Hansson C et al (2012) The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors
Visceral and Ectopic Fat, 353-361
Additional information Journal peer review information : Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work
The activation of GLP-1 receptors slows down stomach emptying, promoting earlier and longer-lasting feelings of fullness
This log will provide valuable insights for you and your doctor, helping to identify patterns and make adjustments to your tapering plan before issues arise